Raluridine
Raluridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[119644-22-3]
Product Name Alternative
935U83
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Nucleoside Antimetabolite/Analog
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/raluridine.html
Purity
99.53
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
OC[C@@H]1[C@@H](F)C[C@H](N2C(NC(C(Cl)=C2)=O)=O)O1
Molecular Formula
C9H10ClFN2O4
Molecular Weight
264.64
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal Fas/TNFRSF6/CD95 Antibody (B-D29) [HRP]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
PAK6 (p21 Activated Kinase 6, p21-activated Kinase 6, p21 (CDKN1A) -activated Kinase 6, PAK-6, Serine/threonine Protein Kinase PAK6, Serine/threonine Protein Kinase PAK-6) (MaxLight 550) discontinued
COP9 Signalosome Subunit 5, NT (COPS5, Jun Activation Domain-binding Protein 1, JAB1, MGC3149, MOV-34, SGN5) -PE discontinued
